The largest trial of the Oxford vaccine is in danger of missing a key deadline to give participants a booster shot because of a month-long pause imposed by an American regulator as it investigates possible side-effects https://t.co/APp5bImj64

— The Times and The Sunday Times (@thetimes) October 7, 2020